argenx announced details from its base in Amsterdam on May 28, 2026, with Alexandra Roy serving as the Investor Relations contact.
11 reports, 3 independent
Updated Oct 15
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 11
- Developments
- 5
- Repetition
- 55%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
argenx announced details from its base in Amsterdam on May 28, 2026, with Alexandra Roy serving as the Investor Relations contact.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Argenx SE released new results from its Amsterdam operations.1 source
argenx announced details from its base in Amsterdam on May 28, 2026.1 source
argenx management confirmed to present at a Chicago conference, with Alexandra Roy serving as IR contact.1 source
Argenx management attended a conference in Boston and used LinkedIn, while Alexandra Roy served as IR contact.1 source
Argenx announced its MuSK agonist program targets for CMS, ALS, and SMA.1 source
Keep exploring
The entities involved
-
Amsterdam
capital and most populous city of the Netherlands
-
Alexandra Roy
researcher (ORCID 0000-0002-8065-2177)
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- manilatimes.net
- manilatimes.net
- manilatimes.net
- stockhouse.com
- manilatimes.net
- GlobeNewswireargenx to Present at Upcoming Investor Conferences August 28, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peopl
- GlobeNewswireargenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025 August 19, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improvin
- GlobeNewswireargenx to Report Half Year 2025 Financial Results and Second Quarter Business Update on July 31, 2025 July 24, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology
- Unknown outlet